Close Menu
Home » In Tufts Study, 10 Cancer Cases Found Among 125K Illumina NIPT Customers

In Tufts Study, 10 Cancer Cases Found Among 125K Illumina NIPT Customers

Jul 14, 2015
|
Molika Ashford
Premium

NEW YORK (GenomeWeb) – Researches from Tufts Medical Center and other institutions working with Illumina have published a new study in which they identified a total of 10 cases of maternal cancer in women who received a discordant or false-positive result after Illumina's non-invasive prenatal testing.

The data, which appeared yesterday in JAMA, represent a retrospective analysis of over 125,000 samples tested by Illumina between February 2012 and September 2014.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

GenomeWeb Premium gives you:
✔ Full site access
✔ Interest-based email alerts
✔ Access to archives

Never miss another important industry story.

Try GenomeWeb Premium now.

You may already have institutional access!

Check if I qualify.

Already a GenomeWeb or 360Dx Premium member?
Login Now.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

The Scan

Add the Missing Data

A federal judge has ruled that drug companies, device manufacturers, and universities need to provide missing clinical data from hundreds of trials to a federal website, ScienceInsider reports.

Two Red Panda Species

A genetic analysis suggests red pandas might actually belong to two different species, New Scientist reports.

Kit Fix

NPR reports that the US Centers for Disease Control and Prevention has fixed the problem with some of its SARS-CoV-2 testing kits.

Nature Papers Explore Epigenetic Factors in Aging, Gene Loss in Animal Kingdom

In Nature this week: epigenetic factors that prevent healthy aging and more.

Mar
18
Featured Webinar

Comparison of Genome-Wide versus Targeted cfDNA Testing for First-Line Prenatal Screening: Real-World Data

Sponsored by
Roche

This webinar will discuss data from a recent real-world comparison study evaluating performance of two cell-free DNA methodologies as first-line prenatal screens.

Mar
31
Featured Webinar

The Role of Single-Cell Functional Biomarkers in Next-Generation Cancer Therapies

Sponsored by
Isoplexis

This webinar will discuss the application of single-cell proteomics and immune-imaging in adoptive cell therapy (ACT) for cancer.

What's Popular?

In Molecular Diagnostics

  1. Guardant Health to Focus on Early Cancer Detection and Monitoring, CDx Development in 2020

    Premium

  2. NanoString Technologies Q4 Revenues Up 23 Percent

  3. Natera Q4 Revenues Rise 24 Percent

  4. BioMérieux Reports 11 Percent Revenue Growth in Q4

  5. NeoGenomics Q4 Revenue Up 40 Percent

Sponsorships

Privacy Policy.  Terms & Conditions.  .  Copyright © 2020 GenomeWeb, a business unit of Crain Communications.  All Rights Reserved.